Referral and Evaluation for Kidney Transplantation Following Implementation of the 2014 National Kidney Allocation System

Autor: Rachel E. Patzer, Mengyu Di, Rebecca Zhang, Laura McPherson, Derek A. DuBay, Matthew Ellis, Joshua Wolf, Heather Jones, Carlos Zayas, Laura Mulloy, Amber Reeves-Daniel, Sumit Mohan, Aubriana C. Perez, Amal N. Trivedi, Stephen O. Pastan, Joel Adler, Alexander Berlin, Teri Browne, Kelley Canavan, Rosalyn Carter, Hannah Graves, Jessica Harding, Mark Kleman, Sana Malik, Prince Mohan, Rebekah Moshiri, Dorothy Muench, Rich Mutell, Jessica Newsome, Michael O’Shea, Laura Plantinga, Samantha Retzloff, Ana Rossi, Leighann Sauls, Robert Stratta, Larissa Teunis, Megan Urbanski
Rok vydání: 2022
Předmět:
Zdroj: American Journal of Kidney Diseases. 80:707-717
ISSN: 0272-6386
Popis: The national kidney allocation system (KAS) implemented in December 2014 in the United States redefined the start of waiting time from the time of waitlisting to the time of kidney failure. Waitlisting has declined post-KAS, but it is unknown if this is due to transplant center practices or changes in dialysis facility referral and evaluation. The purpose of this study was to assess the impact of the 2014 KAS policy change on referral and evaluation for transplantation among a population of incident and prevalent patients with kidney failure.Cohort study.37,676 incident (2012-2016) patients in Georgia, North Carolina, and South Carolina identified within the US Renal Data System at 9 transplant centers and followed through December 2017. A prevalent population of 6,079 patients from the same centers receiving maintenance dialysis in 2012 but not referred for transplantation in 2012.KAS era (pre-KAS vs post-KAS).Referral for transplantation, start of transplant evaluation, and waitlisting.Multivariable time-dependent Cox models for the incident and prevalent population.Among incident patients, KAS was associated with increased referrals (adjusted HR, 1.16 [95% CI, 1.12-1.20]) and evaluation starts among those referred (adjusted HR, 1.16 [95% CI, 1.10-1.21]), decreased overall waitlisting (adjusted HR, 0.70 [95% CI, 0.65-0.76]), and lower rates of active waitlisting among those evaluated compared to the pre-KAS era (adjusted HR, 0.81 [95% CI, 0.74-0.90]). Among the prevalent population, KAS was associated with increases in overall waitlisting (adjusted HR, 1.74 [95% CI, 1.15-2.63]) and active waitlisting among those evaluated (adjusted HR, 2.01 [95% CI, 1.16-3.49]), but had no significant impact on referral or evaluation starts among those referred.Limited to 3 states, residual confounding.In the southeastern United States, the impact of KAS on steps to transplantation was different among incident and prevalent patients with kidney failure. Dialysis facilities referred more incident patients and transplant centers evaluated more incident patients after implementation of KAS, but fewer evaluated patients were placed onto the waitlist. Changes in dialysis facility and transplant center behaviors after KAS implementation may have influenced the observed changes in access to transplantation.
Databáze: OpenAIRE